| Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
|---|---|---|---|---|---|---|---|
| Primex-40 | |||||||
| The Ramaraju Surgical Cotton Mills Limited |
|
Particulars |
31-03-2026 |
31-03-2025 |
|
Non-Current Assets |
|
|
|
Property, Plant &
Equipment |
223.91 |
248.04 |
|
Capital
Work-in-Progress |
0.58 |
0.51 |
|
Investment Property |
0.05 |
0.05 |
|
Goodwill |
19.52 |
19.52 |
|
Intangible Assets |
3.48 |
4.14 |
|
Investments in
Associates |
180.87 |
173.06 |
|
Other Investments |
5.74 |
5.80 |
|
Other Financial Assets
|
3.40 |
4.59 |
|
Deferred Tax Assets |
28.53 |
21.47 |
|
Other Non-Current
Assets |
0.55 |
0.65 |
|
Current Assets |
|
|
|
Inventories |
157.27 |
131.73 |
|
Trade Receivables |
184.14 |
86.04 |
|
Cash and Cash
Equivalents |
5.09 |
1.11 |
|
Bank Balance other
than Cash and Cash Equivalents |
0.04 |
0.06 |
|
Other Financial Assets
|
11.44 |
5.70 |
|
Current Tax Assets |
1.60 |
1.24 |
|
Other Current Assets |
32.17 |
21.06 |
|
Total Assets |
858.35 |
724.75 |
|
Equity |
|
|
|
Equity Share Capital |
5.82 |
5.82 |
|
Other Equity |
193.33 |
227.33 |
|
Non-Controlling
Interest |
1.24 |
2.58 |
|
Non-Current Liabilities |
|
|
|
Borrowings |
195.21 |
221.85 |
|
Provisions |
1.06 |
1.08 |
|
Deferred Tax
Liabilities |
0.49 |
0.18 |
|
Other Non-Current
Liabilities |
0.68 |
0.70 |
|
Current Liabilities |
|
|
|
Borrowings |
378.60 |
212.57 |
|
Trade Payables - Micro
& Small Enterprises |
3.52 |
1.94 |
|
Trade Payables -
Others |
48.59 |
30.49 |
|
Other Financial
Liabilities |
20.41 |
12.14 |
|
Other Current
Liabilities |
4.59 |
3.80 |
|
Provisions |
4.82 |
4.27 |
|
Total Equity and Liabilities |
858.35 |
724.75 |
The Ramaraju Surgical Cotton Mills Limited Consolidated Profit & Loss Statement (Rs in Crores)
|
Particulars |
31-03-2026 |
31-03-2025 |
|
Income |
|
|
|
Revenue from
Operations |
498.80 |
401.09 |
|
Other Income |
5.47 |
5.03 |
|
Total Income |
504.26 |
406.12 |
|
Expenses |
|
|
|
Cost of Materials
Consumed |
242.90 |
220.54 |
|
Purchases of
Stock-in-Trade |
83.80 |
47.52 |
|
Changes in Inventories
of Finished Goods and Work-in-Progress |
-11.00 |
-15.60 |
|
Employee Benefit
Expenses |
67.94 |
62.93 |
|
Finance Cost |
45.31 |
38.58 |
|
Depreciation and
Amortisation Expenses |
27.87 |
29.48 |
|
Other Expenses |
97.53 |
83.09 |
|
Total Expenses |
554.35 |
466.54 |
|
Profit/(Loss) before Exceptional Items and Tax |
-50.09 |
-60.42 |
|
Exceptional Items -
Profit on Sale of Investment in Associates |
- |
16.90 |
|
Profit/(Loss) before Tax |
-50.09 |
-43.52 |
|
Excess Income Tax
Provision related to Earlier Years Withdrawn |
0.02 |
- |
|
Deferred Tax |
-6.75 |
-15.68 |
|
MAT Credit
(Taken)/Withdrawn related to Earlier Year |
- |
5.46 |
|
Profit/(Loss) for the Year before Share of Profit/(Loss) of
Associates |
-43.36 |
-33.30 |
|
Share of Net Profit
after Tax of Associates (Equity Method) |
8.39 |
4.08 |
|
Profit/(Loss) for the Year |
-34.96 |
-29.21 |
|
Other Comprehensive Income |
|
|
|
Re measurement
Profit/(Loss) on Defined Benefit Obligation (net) |
1.24 |
-0.14 |
|
Fair Value Gain on
Equity Instruments through OCI (net) |
0.01 |
0.02 |
|
Share of OCI of
Associates (Equity Method) |
0.01 |
-0.15 |
|
OCI - Foreign Currency
Translation |
-0.29 |
0.83 |
|
Total Comprehensive Income/(Loss) for the Year, Net of Tax |
-34.00 |
-28.66 |
|
Earnings per Equity Share |
|
|
|
Basic & Diluted |
-60.13 |
-50.24 |
|
Particulars |
31-03-2026 |
31-03-2025 |
|
Cash Flow from Operating Activities |
|
|
|
Profit/(Loss) before
Tax and Exceptional Items |
-50.09 |
-60.42 |
|
Adjustments: |
|
|
|
Depreciation &
Amortisation |
27.87 |
29.48 |
|
Finance Cost |
45.31 |
38.58 |
|
Interest Received |
-2.58 |
-2.73 |
|
(Profit)/Loss on Sale
of Assets |
-0.40 |
0.63 |
|
Government Grants |
-0.01 |
-0.01 |
|
Operating Profit before Working Capital Changes |
20.10 |
5.54 |
|
Trade Receivables |
-98.10 |
-39.66 |
|
Inventories |
-25.55 |
-16.12 |
|
Loans and Advances |
-15.38 |
2.37 |
|
Trade Payables &
Current Liabilities |
30.34 |
18.62 |
|
Cash Generated from Operations |
-88.58 |
-29.26 |
|
Income Taxes Paid
(Net) |
-0.36 |
0.32 |
|
Net Cash Flows from/(used in) Operating Activities |
-88.94 |
-28.94 |
|
Cash Flow from Investing Activities |
|
|
|
Purchase of PPE,
Intangible Assets and Investment Property (net, incl. CWIP) |
-4.87 |
-1.49 |
|
Proceeds from Sale of
Investment in Associates |
0.06 |
40.30 |
|
Proceeds from Sale of
Property, Plant and Equipment |
2.22 |
4.02 |
|
Interest Received |
2.29 |
2.36 |
|
Net Cash Flows from/(used in) Investing Activities |
-0.31 |
45.19 |
|
Cash Flow from Financing Activities |
|
|
|
Proceeds from Long
Term Borrowings |
45.00 |
56.00 |
|
Repayment of Long Term
Loan |
-71.65 |
-68.97 |
|
Proceeds/(Repayment)
of Deposits |
179.35 |
9.04 |
|
Proceeds/(Repayment)
of Short Term Borrowings (Net) |
-13.31 |
-12.09 |
|
Acquisition of
Non-Controlling Interest |
-1.35 |
-1.40 |
|
Finance Cost |
-44.84 |
-38.37 |
|
Net Cash Flows from/(used in) Financing Activities |
93.20 |
-55.80 |
|
Net Increase/(Decrease) in Cash and Cash Equivalent |
3.95 |
-39.54 |
|
Opening Balance of
Cash and Cash Equivalents |
1.17 |
40.71 |
|
Closing Balance of Cash and Cash Equivalents |
5.12 |
1.17 |
Summary
of the Cash Flow Statement for the years 2026 and 2025:
Cash Flow
from Operating Activities:
Net cash used in operating activities increased significantly to Rs. 88.94 crore in FY 2026, compared with Rs. 28.94 crore in FY 2025, indicating continued pressure
on the company’s core operations. Although operating profit before working
capital changes improved to Rs. 20.10 crore from Rs. 5.54
crore, this was more than offset by adverse working capital
movements. The largest outflow came from trade receivables of Rs. 98.10
crore, compared with Rs. 39.66 crore in FY 2025, suggesting
that substantial sales remained tied up in receivables. Inventories also
absorbed Rs. 25.55 crore, while loans
and advances used another Rs. 15.38 crore.
The increase in trade payables and current liabilities provided a partial
offset of Rs. 30.34 crore. Overall, the operating cash flow reflects weak cash
conversion and higher working
capital requirements.
Cash Flow
from Investing Activities:
Net cash used in investing activities was relatively low at Rs. 0.31 crore in
FY 2026, compared with net cash generated of Rs. 45.19 crore in FY 2025. The
major change was the sharp reduction in proceeds from the sale of investments
in associates, which fell from Rs. 40.30 crore to just Rs. 0.06 crore. The
company spent Rs. 4.87 crore on PPE, intangible assets and investment property,
higher than Rs. 1.49 crore in the previous year, indicating somewhat higher
capital expenditure. This was partly offset by Rs. 2.22 crore from the sale of
PPE and Rs. 2.29 crore of interest received. Overall, investing activities were
broadly cash-neutral in FY 2026, but the absence of the large investment-sale
proceeds seen in FY 2025 reduced liquidity support.
Cash Flow
from Financing Activities:
Financing activities generated Rs. 93.20 crore in FY 2026, compared with a cash
outflow of Rs. 55.80 crore in FY 2025. The key driver was a substantial
increase in deposits, which generated Rs. 179.35 crore, compared with only Rs.
9.04 crore in FY 2025. The company also raised Rs. 45 crore through long-term
borrowings. However, these inflows were partly absorbed by Rs. 71.65 crore of
long-term loan repayments, Rs. 13.31 crore reduction in short-term borrowings
and Rs. 44.84 crore of finance costs. Therefore, the positive financing cash
flow was largely supported by higher deposit mobilisation and borrowing, rather
than internally generated cash.
Net
Increase/(Decrease) in Cash:
The company 's cash and cash equivalents increased by Rs. 3.95 crore in FY 2026,
reversing the Rs. 39.54 crore decline in FY 2025. However, the improvement was
primarily due to financing inflows of Rs. 93.20 crore, which more than offset
the Rs. 88.94 crore operating cash outflow and Rs. 0.31 crore investing
outflow. Consequently, the improvement in cash should not be interpreted as an
improvement in underlying operating liquidity, as the business continued to
consume substantial cash from operations.
Financial
Ratios of The
Ramaraju Surgical Cotton Mills Ltd :
|
Particulars |
31-03-2026 |
31-03-2025 |
|
Current
Ratio |
1.04 |
1.20 |
|
Debt -
Equity Ratio |
7.66 |
4.01 |
|
Debt
Service Coverage Ratio |
0.44 |
0.32 |
|
Return
on Equity Ratio |
-38.76 |
6.45 |
|
Inventory
Turnover Ratio |
100 |
101 |
|
Trade
Receivable Turnover Ratio |
97 |
64 |
|
Trade
Payable Turnover Ratio |
18 |
15 |
|
Net
Capital Turnover Ratio |
179 |
150 |
|
Net
Profit Ratio |
-7.11 |
1.54 |
|
Return
on Capital Employed |
2.19 |
8.86 |
|
Return
on Investments (Assets) |
-5.30 |
1.08 |
Summary of Financial
Ratios for the year 2026 and 2025:
Current Ratio:
The Current Ratio declined from 1.20 in FY 2025 to 1.04
in FY 2026, indicating a weakening in short-term liquidity. Although the ratio
remains marginally above 1, the company 's current assets provide only a limited
cushion over its current liabilities. This is consistent with the negative
operating cash flow and suggests that the company has relatively limited
liquidity headroom.
Debt-Equity Ratio:
The Debt-Equity Ratio increased sharply from 4.01x to
7.66x, indicating a substantial rise in financial leverage. The company is
increasingly dependent on debt relative to shareholders ' funds, which increases
financial risk and interest obligations. The deterioration is particularly
significant given the company 's negative profitability.
Debt Service
Coverage Ratio:
DSCR improved from 0.32x to 0.44x, but remains well
below 1.0x. This indicates that the company 's internally generated earnings are
still insufficient to comfortably cover its debt servicing obligations. Despite
the improvement, debt repayment capacity remains weak.
Return on Equity:
ROE deteriorated significantly from a positive 6.45% in
FY 2025 to negative 38.76% in FY 2026. This reflects the company 's loss during
FY 2026 and indicates that shareholders ' capital generated a negative return.
The sharp deterioration points to a significant decline in overall
profitability and shareholder value creation.
Inventory Turnover
Ratio:
Inventory turnover remained broadly stable, moving from
101 days to 100 days. This indicates that there was little change in the time
taken to convert inventory into sales. Inventory management therefore appears
relatively stable year-on-year, although the relatively long holding period
continues to tie up working capital.
Trade Receivable Turnover
Ratio:
The trade receivable cycle deteriorated considerably,
increasing from 64 days to 97 days. This indicates that the company is taking
substantially longer to collect money from customers. The deterioration is
consistent with the Rs. 98.10 crore increase in cash tied up in trade
receivables and is a major contributor to the company 's negative operating cash
flow.
Trade Payable
Turnover Ratio:
Trade payable days increased from 15 days to 18 days,
indicating that the company is taking slightly longer to pay its suppliers.
This provides some short-term working capital support and partially offsets the
increase in receivable days. However, the increase is insufficient to
compensate for the much larger deterioration in collections.
Net Capital Turnover
Ratio:
The Net Capital Turnover Ratio increased from 150 days
to 179 days. This indicates a higher amount of net working capital being
employed relative to the company 's operations. While higher turnover can
sometimes indicate better utilisation, in this case the increase should be
viewed alongside the sharp rise in receivables and negative operating cash
flow, suggesting greater working capital intensity.
Net Profit Ratio:
The Net Profit Ratio declined sharply from a positive
1.54% to negative 7.11%. This indicates that the company moved from generating
a small net profit to incurring a significant net loss relative to revenue. The
deterioration reflects higher costs and financial pressure and is one of the
key reasons for the negative ROE.
Return on Capital
Employed:
ROCE declined from 8.86% to 2.19%, indicating a
substantial reduction in the efficiency with which the company generates
operating returns from its long-term capital. Although ROCE remains positive,
the sharp decline suggests weaker operating profitability and inefficient
utilisation of the capital employed.
Return on
Investments:
Return on Investment fell from 1.08% to negative 5.30%,
indicating that the company 's asset base generated a negative return during FY
2026. This reflects the deterioration in profitability and suggests that the
company 's assets are currently not generating adequate returns. Overall, the
ratio trend points to weak profitability, higher leverage and increasing
working-capital pressure in FY 2026.